These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21039311)

  • 1. Medical conditions in fibromyalgia patients and their relationship to pregabalin efficacy: pooled analysis of Phase III clinical trials.
    Bhadra P; Petersel D
    Expert Opin Pharmacother; 2010 Dec; 11(17):2805-12. PubMed ID: 21039311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.
    Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B;
    J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study.
    Roth T; Lankford DA; Bhadra P; Whalen E; Resnick EM
    Arthritis Care Res (Hoboken); 2012 Apr; 64(4):597-606. PubMed ID: 22232085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
    Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
    J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
    Arnold L; Mease P; Silverman S
    Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
    Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
    J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis.
    Argoff CE; Emir B; Whalen E; Ortiz M; Pauer L; Clair A
    Pain Med; 2016 Nov; 17(11):2100-2108. PubMed ID: 27257288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
    Emir B; Murphy TK; Petersel DL; Whalen E
    Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
    Straube S; Derry S; Moore RA; McQuay HJ
    Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
    Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
    Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
    Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
    Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia.
    Ohta H; Oka H; Usui C; Ohkura M; Suzuki M; Nishioka K
    Arthritis Res Ther; 2012 Oct; 14(5):R217. PubMed ID: 23062189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change.
    Byon W; Ouellet D; Chew M; Ito K; Burger P; Pauer L; Zeiher B; Corrigan B
    J Clin Pharmacol; 2010 Jul; 50(7):803-15. PubMed ID: 20357295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the fibromyalgia impact questionnaire at baseline as a predictor for time to pain improvement in two clinical trials of pregabalin.
    Bushmakin AG; Cappelleri JC; Chandran AB; Zlateva G
    Int J Clin Pract; 2013 Jan; 67(1):52-9. PubMed ID: 23241048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome.
    Russell IJ; Crofford LJ; Leon T; Cappelleri JC; Bushmakin AG; Whalen E; Barrett JA; Sadosky A
    Sleep Med; 2009 Jun; 10(6):604-10. PubMed ID: 19410509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.